This test is most useful if any of these apply to you.
You inhale invisible chemicals every day. Some come from car exhaust, some from new furniture, some from cigarette smoke, and some from working around plastics, paints, or fuels. Your body breaks many of these compounds down and sends the leftovers out through your urine, where they can be measured.
PGA (phenylglyoxylic acid) is one of those leftovers. It is a urinary fingerprint of two common industrial solvents called styrene and ethylbenzene, and looking at it can show whether you are absorbing more of these chemicals than the average person, even when you feel fine.
Styrene is used to make plastics, foam, and rubber. Ethylbenzene shows up in paints, varnishes, fuels, and cigarette smoke. Once these chemicals get into your bloodstream, your liver converts them into mandelic acid first, then into PGA. Both end up in your urine, where labs can measure them.
In a U.S. population study of 4,690 adults from the NHANES survey, urinary PGA tracked exposure to ethylbenzene and styrene from sources including tobacco smoke, certain foods, and indoor air. PGA on its own is not a disease marker. It is an exposure marker, telling you something about what you have been breathing or absorbing in recent days.
Until recently, PGA was used almost entirely in occupational medicine to check whether factory workers were over-exposed to solvents. That has started to change. Several large studies in non-occupational populations have found that people with higher urinary PGA also tend to have worse outcomes across multiple body systems.
A six-year study of 2,219 adults tracked urinary mandelic acid plus PGA, the combined signal of styrene and ethylbenzene exposure. People with higher levels were more likely to develop type 2 diabetes, and the relationship was dose-dependent: as exposure went up, diabetes risk went up. The risk was even stronger in people with a high genetic risk score for diabetes, suggesting your inherited risk and your environmental exposure can compound each other.
What this means for you: if you already know you carry diabetes risk in your family, knowing whether you also carry a high solvent-exposure burden gives you something concrete to address rather than waiting for blood sugar to drift.
In a study of 1,160 petrochemical workers, the combined signal of mandelic acid plus PGA was linked in a straight-line fashion to lower estimated kidney filtration rate (eGFR, a measure of how well your kidneys clean your blood) and to higher rates of mild kidney impairment. PGA and mandelic acid were among the strongest contributors when researchers analyzed the chemical mixture as a whole.
Among 6,578 middle-aged and older U.S. adults, higher urinary PGA, mandelic acid, and another ethylbenzene metabolite were associated with greater odds of osteoarthritis. The researchers found that biological aging markers partly explained the link, suggesting solvent exposure may speed up some of the wear-and-tear processes behind joint disease.
In a study of 7,007 U.S. adults, urinary PGA and other VOC (volatile organic compound) metabolites were positively linked to two systemic inflammation indices, often in a J-shaped pattern (risk is elevated at both very low and very high levels but lowest in a middle range). Smokers were noticeably more vulnerable to these inflammatory effects.
In petrochemical workers, those with higher PGA and related solvent metabolites had elevated white blood cells, lymphocytes, and liver enzymes, pointing to inflammatory and hepatic effects from chronic exposure.
PGA is a Tier 3 research marker. There is no consensus clinical cutpoint for the general public. The numbers below come from population biomonitoring and occupational research, are typically measured in micrograms per gram of creatinine (a unit that adjusts for how concentrated your urine is), and are illustrative orientation rather than universal targets. Your lab will likely use slightly different cutpoints, units, or methods.
| Tier | Context | What It Suggests |
|---|---|---|
| Background | Typical of nonsmoking U.S. adults in NHANES | Reflects everyday environmental exposure from indoor air, traffic, and food |
| Elevated | Higher than the general-population range | Suggests above-average solvent exposure, often from tobacco smoke, occupational settings, or indoor environments with off-gassing |
| Occupational | At or above industrial Biological Exposure Index thresholds | Indicates exposure consistent with workplace solvent contact and warrants investigation of source |
Compare your results within the same lab over time for the most meaningful trend. Single readings are noisy because PGA reflects recent exposure rather than a stable internal level.
PGA is a snapshot of recent exposure, with styrene having a biological half-life of roughly eight hours. That means a single reading tells you what you breathed in over the last day or two, not what you carry around as a baseline. To make this useful, you need a trend.
Get a baseline now. If the result is high, retest in 8 to 12 weeks after looking at the obvious sources (smoking, vaping, occupational exposure, recent home renovation, time spent in heavy traffic). If you change something, retest after 3 months to see whether the level moved. If the result is in the background range, an annual recheck is reasonable, especially if your environment changes.
An elevated PGA is not a diagnosis. It is a signal to investigate the source. Start with the obvious: tobacco or cannabis smoke (yours or someone else's), workplace solvent exposure, recent home renovation or new furniture, and proximity to traffic or industrial sites. If the result stays elevated after addressing these, consider pairing it with companion exposure markers to map your full chemical burden, including a metabolite of toluene and xylene (2-, 3-, 4-methylhippuric acid), benzene (N-acetyl phenyl cysteine), and acrylonitrile (N-acetyl 2-cyanoethyl cysteine).
If you have other markers that point in the same direction, such as elevated inflammation, declining kidney filtration, or rising blood sugar, treating chronic solvent exposure as part of your prevention plan is reasonable. For occupational exposure, an occupational medicine physician can help interpret your level against workplace thresholds and guide whether engineering controls or personal protective equipment need to be reviewed.
Evidence-backed interventions that affect your PGO level
Phenylglyoxylic Acid is best interpreted alongside these tests.
Phenylglyoxylic Acid is included in these pre-built panels.